Chondroitin sulfate proteoglycan 4 (693-708)

Chondroitin sulfate proteoglycan 4

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: ta-367

Synonyms/Alias:Chondroitin sulfate proteoglycan 4 (693-708)

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
Sequence
VGQDVSVLFRVTGALQ
Areas of Interest
Antigen-presenting Cells; Cancer Research

Chondroitin sulfate proteoglycan 4 (693-708) is a synthetic peptide fragment corresponding to amino acid residues 693 through 708 of the human chondroitin sulfate proteoglycan 4 (CSPG4), also known as neuron-glial antigen 2 (NG2). As a defined segment of a large transmembrane proteoglycan, this peptide is of particular interest in biochemical and cell biology research focused on extracellular matrix interactions, cell signaling, and the structural biology of proteoglycans. The CSPG4 protein plays a multifaceted role in cellular adhesion, migration, and intercellular communication, making its peptide fragments valuable tools for dissecting functional domains and elucidating molecular mechanisms underlying these processes.

Epitope mapping: Synthetic peptides derived from CSPG4, such as the 693-708 fragment, are widely employed in epitope mapping studies to define antibody binding sites and characterize immune recognition patterns. By providing a discrete linear sequence from the parent protein, the peptide enables researchers to assess epitope specificity, affinity, and cross-reactivity of monoclonal or polyclonal antibodies. This application is essential for the development of reliable immunodetection reagents and for advancing our understanding of protein-antibody interactions in both basic and applied immunology.

Protein-protein interaction studies: The 693-708 segment of CSPG4 serves as a valuable probe for investigating direct and indirect protein-protein interactions involving the NG2 proteoglycan. In vitro binding assays, such as pull-down experiments or surface plasmon resonance, utilize this peptide to identify potential binding partners, map interaction domains, and quantify binding affinities. These studies provide insights into the molecular interfaces that mediate cell-matrix adhesion and modulate signaling pathways relevant to cellular communication and tissue organization.

Cell signaling research: CSPG4-derived peptides are instrumental in dissecting the signaling functions of the parent protein, particularly in the context of receptor-mediated pathways. The 693-708 peptide can be used to modulate or compete for specific protein interactions, enabling the study of downstream signaling events and the identification of critical residues involved in pathway activation or inhibition. Such approaches facilitate the elucidation of mechanisms controlling cell proliferation, differentiation, and migration, which are central to developmental biology and cancer research.

Peptide-based assay development: Defined peptide fragments like CSPG4 (693-708) are frequently incorporated into the design of quantitative assays, including enzyme-linked immunosorbent assays (ELISAs) and fluorescence-based detection systems. Their use as standardized antigens or competitors allows for the sensitive and specific measurement of antibody titers, biomarker levels, or enzymatic activities in complex biological samples. The reproducibility and well-characterized nature of synthetic peptides support the development of robust, high-throughput analytical platforms for laboratory research.

Structural biology investigations: The 693-708 peptide provides a model system for studying the conformational properties and structural motifs of CSPG4. Through techniques such as nuclear magnetic resonance (NMR) spectroscopy or circular dichroism, researchers can analyze the secondary structure, flexibility, and potential post-translational modifications of this sequence. These structural insights contribute to a deeper understanding of proteoglycan architecture and inform the rational design of peptide mimetics or inhibitors targeting CSPG4-mediated processes.

Source#
Homo sapiens (human)
Epitope
693-708
Restricting HLA
HLA-DR11
References
Erfurt; J Immunol 2007

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Epitope Mapping ServicesPeptide Analysis ServicesPeptide Nucleic Acids SynthesiscGMP Peptide ServicePeptide Modification ServicesPeptide CDMOPeptide Synthesis ServicesCustom Conjugation Service
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers